Consumer Health industry in Colombia

Growth in consumer health remained strong in 2011, just slightly higher than the growth rate seen in 2010. Growth was fuelled by bad weather, but also by the continued growth of the economy and disposable incomes in general. However, contraband sales continued to limit growth. The regulatory agency INVIMA reacted with more inspections of retail outlets and greater communication about which products are not authorised to be sold in Colombia.

Bad weather boosts demand
Global warming and the climate phenomena El Niño and La Niña deteriorated the health of the population. The development of a viral flu accompanied by gastrointestinal complaints repeatedly affected much of the population, increasing their consumption of analgesics, cough, cold and allergy (hay fever) remedies and digestive remedies.

GlaxoSmithKline de Colombia maintains the lead in consumer health
GlaxoSmithKline de Colombia remained the leading company in consumer health in 2011. The brand Dolex achieved the leading position through strong advertising, and its success was also due to having different presentations adapted to different buyers’ financial capacity. Tecnoquímicas remained in second position, but saw strong growth in 2011 as a result of strategies developed specifically to take share from the brands Dolex and Advil. Its strategy was to develop packaging with similar characteristics, with mass media advertising and cheaper prices.

Healthfood shops see an increase in share
Parapharmacies/drugstores is losing share to the growing number of healthfood shops and larger drug shelves in supermarkets. Distribution channels compete with strategies such as customer loyalty through the web, and exclusive benefits for members in stores. Locatel opened 11 new stores in the country, and Farmatodo was one of the most active companies in the network, with 32,000 followers on Twitter.

Buy your copy of report @ http://www.reportsnreports.com/reports/160655-consumer-health-in-colombia.html  

Report Details :
Published: May 2012
 Price: Single User License:US $ 2400   

 

The Consumer Health in Colombia market research report includes:

• Analysis of key supply-side and demand trends
• Detailed segmentation of international and local products
• Historic volumes and values, company and brand market shares
• Five year forecasts of market trends and market growth 
• Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

• What is the market size of Consumer Health in Colombia?
• What are the major brands in Colombia?
• What are the main trends in OTC Healthcare?

Why buy this report?

• Gain competitive intelligence about market leaders
• Track key industry trends, opportunities and threats
• Inform your marketing, brand, strategy and market development, sales and supply functions

 

Consumer Health in Colombia

Growth remains strong, but limited by contraband
Growth in consumer health remained strong in 2011, just slightly higher than the growth rate seen in 2010. Growth was fuelled by bad weather, but also by the continued growth of the economy and disposable incomes in general. However, contraband sales continued to limit growth. The regulatory agency INVIMA reacted with more inspections of retail outlets and greater communication about which products are not authorised to be sold in Colombia.

Bad weather boosts demand
Global warming and the climate phenomena El Niño and La Niña deteriorated the health of the population. The development of a viral flu accompanied by gastrointestinal complaints repeatedly affected much of the population, increasing their consumption of analgesics, cough, cold and allergy (hay fever) remedies and digestive remedies.

GlaxoSmithKline de Colombia maintains the lead in consumer health
GlaxoSmithKline de Colombia remained the leading company in consumer health in 2011. The brand Dolex achieved the leading position through strong advertising, and its success was also due to having different presentations adapted to different buyers’ financial capacity. Tecnoquímicas remained in second position, but saw strong growth in 2011 as a result of strategies developed specifically to take share from the brands Dolex and Advil. Its strategy was to develop packaging with similar characteristics, with mass media advertising and cheaper prices.

Healthfood shops see an increase in share
Parapharmacies/drugstores is losing share to the growing number of healthfood shops and larger drug shelves in supermarkets. Distribution channels compete with strategies such as customer loyalty through the web, and exclusive benefits for members in stores. Locatel opened 11 new stores in the country, and Farmatodo was one of the most active companies in the network, with 32,000 followers on Twitter.

Get Your Copy of Report @ http://www.reportsnreports.com/reports/160655-consumer-health-in-colombia.html  

Report Details :
Published: May 2012
Price: US $2400

    

Table of Contents
Consumer Health in Colombia - Industry Overview
EXECUTIVE SUMMARY
Growth remains strong, but limited by contraband
Bad weather boosts demand
GlaxoSmithKline de Colombia maintains the lead in consumer health
Healthfood shops see an increase in share
Price control could limit forecast growth
KEY TRENDS AND DEVELOPMENTS
Overweight and obese population increasing
High levels of stress are felt in large cities
Self-medication is a popular practice in Colombia
Colombian government commits to biotechnological development
Demographic changes impact consumer health
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 2 Life Expectancy at Birth 2006-2011
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2006-2011
Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 5 Consumer Health Company Shares 2007-2011
Table 6 Consumer Health Brand Shares 2008-2011
Table 7 Penetration of Private Label by Category 2006-2011
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
OTC registration and classification
Delisting or de-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches
Summary 1 OTC Switches 2009-2011
  

Consumer Health in New Zealand

The Consumer Health in New Zealand market research report includes:

• Analysis of key supply-side and demand trends
• Detailed segmentation of international and local products
• Historic volumes and values, company and brand market shares
• Five year forecasts of market trends and market growth 
• Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

• What is the market size of Consumer Health in New Zealand?
• What are the major brands in New Zealand?
• What are the main trends in OTC Healthcare?

New Zealand Consumer Health Industry

Published: March 2012
Price: Single User License: US$ 2400

 
Few points from Table of Content Consumer Health in New Zealand - Industry Overview
EXECUTIVE SUMMARY
MARKET DATA
Table 1 Penetration of Private Label by Sector 2006-2011
Consumer Health in New Zealand - Industry Context
EXECUTIVE SUMMARY
Consumer health remains buoyant during 2011
Prevention remains a major focus area
Vitaco Health continues to lead sales
Direct selling channel records growth in 2011
Value sales expected to increase over forecast period
KEY TRENDS AND DEVELOPMENTS
New Zealand’s ageing population
New Zealand to be smoke-free by 2025
Natural health products bill
Christchurch earthquake
Natural healing and prevention
MARKET INDICATORS
Table 2 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 3 Life Expectancy at Birth 2006-2011
MARKET DATA
Table 4 Sales of Consumer Health by Category: Value 2006-2011
Table 5 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 6 Consumer Health Company Shares 2007-2011
Table 7 Consumer Health Brand Shares 2008-2011
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches
Summary 1 OTC - Switches 2009-2011
DEFINITIONS
SOURCES
Summary 2 Research Sources
Consumer Health in New Zealand - Company Profiles
Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)
STRATEGIC DIRECTION
KEY FACTS
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Douglas Pharmaceuticals: Competitive Position 2011

Consumer Health in Denmark

The report Consumer Health in Denmark market research report includes:

• Analysis of key supply-side and demand trends
• Detailed segmentation of international and local products
• Historic volumes and values, company and brand market shares
• Five year forecasts of market trends and market growth 
• Robust and transparent market research methodology, conducted in-country

OTC sales record modest growth in 2011

Value sales of consumer health increased slightly in Denmark in 2011. In comparison to 2010, the market registered a stronger growth rate. With the more favourable economic context, demand was in general slightly higher. Even though consumer health products continued to be necessities, safety concerns and a downward price trend were the key factors preventing a stronger value growth in OTC sales. Experts’ warnings raised consumers’ concern about the side effects and potential risks of taking certain products such as calming and sleeping, NRT smoking cessation aids and vitamins and dietary supplements. Categories regarded as necessities, such as digestive remedies, analgesics or cough, cold and allergy (hay fever) remedies maintained value growth in 2011.

Denmark Consumer Health Market

Published: March 2012
Price: Single User License: US$ 2400



Consumer concerns and decreasing unit prices stagnate value growth

Physicians and nutrition experts have been increasingly warning Danish consumers about the dangers of overuse, the possible side effects and the possibility of dependency when taking vitamins, herbal/traditional products and NRT smoking cessation aids. Furthermore, the National Food Institute also suggested that it is not necessary for adolescents to take dietary supplements as most people can get the necessary vitamins and minerals through a healthy diet. Thus unfavourable views from the authorities and experts made consumers think twice before purchasing these products. This, together with the decreasing average unit prices, was the key factor behind the slowdown in value growth of consumer health products. The development of private label, cheaper generic products and expanding distribution affected unit prices in a downwards trajectory.

Chemists/pharmacies continues to be the most common outlet for consumer health products

Chemists/pharmacies continue to be the leading outlet channel for consumer health sales. Yet despite the fact that this channel accounts for the majority of consumer health sales, it is losing its foothold as other outlet channels, such as parapharmacies/drugstores, discounters and internet retailing, are gaining in importance. A significant amount of NRT cessation aids, vitamins and dietary supplements, sports nutrition, wound care and weight management products are purchased through other channels, such as grocery retailers and through internet retailing. This is due to convenience, as consumers find it convenient to shop for their healthcare products whilst doing their grocery shopping.

Stagnant sales predicted for the forecast period

Sales of consumer health are expected to record a minimal constant value CAGR over the forecast period. Growth will remain driven by similar factors as in the review period including the health and wellness trend, self-medication, an ageing Danish population and increased product segmentation. Market maturity, increased competition from private label and cheaper generic and parallel imports will remain the most significant challenge to value sales in consumer health.